BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19496740)

  • 1. Use of single-pill combination therapy in the evolving paradigm of hypertension management.
    Calhoun DA
    Expert Opin Pharmacother; 2009 Aug; 10(12):1869-74. PubMed ID: 19496740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in blood pressure control and the potential role of single-pill combination therapies.
    Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
    Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM; Hilkert R
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for single-pill triple therapy in hypertension.
    Elijovich F; Laffer C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with antihypertensive therapy: raising the bar of expectations.
    Rudd P
    Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose triple-combination treatments in the management of hypertension.
    Ram CV
    Manag Care; 2013 Dec; 22(12):45-55. PubMed ID: 24555265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the patient with hard-to-control hypertension.
    Oparil S; Calhoun DA
    Am Fam Physician; 1998 Mar; 57(5):1007-14, 1019-20. PubMed ID: 9518949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy as first-line treatment of arterial hypertension.
    Ruzicka M; Leenen FH
    Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home blood pressure monitoring: a new standard method for monitoring hypertension control in treated patients.
    Pickering TG
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):762-3. PubMed ID: 18852711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aim, design and methods of the 'reasons for not intensifying antihypertensive treatment' (RIAT): an international registry in essential hypertension.
    Ferrari P; Kim SK; Wu CJ; Pham NV; Ageev F; Hermosillo LD; Esper R;
    J Hum Hypertens; 2006 Jan; 20(1):31-6. PubMed ID: 16252001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations.
    Parati G
    J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance--and improving it--in hypertension.
    Elliott WJ
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):56-61. PubMed ID: 12971594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the management of hypertension.
    Kaplan NM
    Can J Cardiol; 2000 Sep; 16(9):1147-52. PubMed ID: 11021958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fixed-dose combinations in the first line of antihypertensive therapy].
    Urbán L; Mészáros A
    Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.